SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-16-012558
Filing Date
2016-04-26
Accepted
2016-04-26 16:04:11
Documents
5
Period of Report
2016-06-15
Effectiveness Date
2016-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2228428zdef14a.htm DEF 14A 373679
2 G890909.JPG g890909.jpg GRAPHIC 18599
3 G102608.JPG g102608.jpg GRAPHIC 5386
4 G93142BGI001.GIF g93142bgi001.gif GRAPHIC 63339
5 G93142BGI002.GIF g93142bgi002.gif GRAPHIC 48121
  Complete submission text file 0001047469-16-012558.txt   561870
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37467 | Film No.: 161592039
SIC: 2834 Pharmaceutical Preparations